Dietary Cholesterol Absorption Inhibitor [EPC]

92277 reported adverse events

Drugs of this class: EZETIMIBE EZETIMIBE AND SIMVASTATIN BEMPEDOIC ACID AND EZETIMIBE

These side effects are most commonly reported by patients taking drugs of the Dietary Cholesterol Absorption Inhibitor [EPC] class:

# Side effect Count
0 FATIGUE 5917
1 NAUSEA 5562
2 MYALGIA 5301
3 DIARRHOEA 4724
4 DRUG INEFFECTIVE 4648
5 DIZZINESS 4427
6 DYSPNOEA 4207
7 HEADACHE 4088
8 ARTHRALGIA 3733
9 PAIN 3677
See all common reactions for Dietary Cholesterol Absorption Inhibitor [EPC]

Drugs of the Dietary Cholesterol Absorption Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMAUROSIS FUGAX 243 0.2256
1 LOW DENSITY LIPOPROTEIN INCREASED 622 0.0803
2 PERSONALITY DISORDER 194 0.0740
3 HIGH DENSITY LIPOPROTEIN DECREASED 202 0.0606
4 MYOPATHY 481 0.0556
5 URINARY TRACT DISORDER 232 0.0515
6 NEPHROGENIC ANAEMIA 232 0.0500
7 DYSLIPIDAEMIA 250 0.0492
8 HAEMORRHAGIC STROKE 351 0.0449
9 ARTERIAL OCCLUSIVE DISEASE 344 0.0437
See all enriched reactions for Dietary Cholesterol Absorption Inhibitor [EPC]